Global push to tackle maternal and newborn deaths has stalled, WHO report finds

(Reuters) – Progress in reducing deaths during pregnancy and childbirth and among newborn infants has stalled since 2015, and over 60 countries are on track to miss 2030 targets at current rates, a World Health Organization report released on Tuesday found. The COVID-19 pandemic, poverty, and worsening humanitarian crises have strained already pressured healthcare systems,…

Read More

Abortion pill case to be heard by conservative, anti-abortion panel

By Brendan Pierson and Jacqueline Thomsen (Reuters) – A case brought by anti-abortion groups seeking to ban the abortion pill mifepristone nationwide will be heard next week by a panel of three deeply conservative judges hostile to abortion rights, a federal appeals court revealed on Monday. The Biden administration is expected to urge the 5th…

Read More

After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic

By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several…

Read More

Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market

By Michael Erman NEW YORK (Reuters) – The enormous demand for weight-loss treatments like Novo Nordisk’s Wegovy could support as many as 10 competing products with annual sales reaching up to $100 billion within a decade, mostly in the United States, industry executives and analysts said. More than half a dozen companies, from Pfizer Inc…

Read More

Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach

By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) -An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease….

Read More